Published • loading... • Updated
'Multi-cancer' blood tests coming to some GP surgeries soon
The government-funded STRIDE-RCT study will test whether one or two tubes of blood can help identify cancers earlier and guide urgent follow-up.
- The University of Birmingham launched the government-funded STRIDE-RCT trial, testing multi-cancer blood assays at GP practices in England to detect 13 malignancies including bowel, pancreatic, and ovarian cancers.
- Around 71,000 people in England are diagnosed annually with pancreatic, stomach, liver, ovarian or bowel cancer, with nearly 35,000 deaths yearly, creating urgent clinical need for earlier detection to improve survival.
- Prof Peter Johnson, NHS England's national clinical director for cancer, said detecting abdomen cancer early is "notoriously difficult" because symptoms can easily mimic less serious conditions, complicating GP diagnosis.
- Michelle Mitchell from Cancer Research said: "GPs have long needed better tools to help them navigate that uncertainty," while Health Secretary Yvette Cooper emphasized identifying patients needing urgent investigation sooner.
- Officials noted a positive blood-test result does not guarantee cancer and a negative result is not an all-clear; separately, an NHS Galleri trial recently failed to meet its primary goal of reducing late-stage diagnoses.
Insights by Ground AI
9 Articles
9 Articles
The IndependentReposted by 
The Independent (US)
The Independent (US)New NHS blood test trial to detect cancer in its earliest stages
·London, United Kingdom
Read Full Article
A blood test designed to detect multiple forms of cancer is starting to be offered to NHS patients.
Coverage Details
Total News Sources9
Leaning Left4Leaning Right1Center1Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 17%
R 16%
Factuality
To view factuality data please Upgrade to Premium
